Mirada Medical launches Caseaccess PET-CT image management software
23 June 2010
Mirada Medical Limited has launched Caseaccess, a software
package that provides remote access to PET-CT and SPECT-CT scans and
reports.
It combines the company's fusion image analysis software with
online image visualisation technologies to provide remote access to
PET-CT and SPECT-CT scans and reports via fast, richly featured
multi-modal quantitative imaging software.
Mirada Medical aims to provide readers with greater clinical
certainty in the diagnosis and treatment of disease by providing
enhanced 3D multi-modal imaging together with powerful
quantification tools that can be used to assess how pathology, for
example malignant tumours, are responding to treatment regimes.
Mirada’s products were launched into the global marketplace in
2001 and are currently sold through leading international imaging
companies including Siemens, Sectra, Carestream, Vital Images and
McKesson.
The company’s technology was founded by one of the world’s
leading imaging scientists, Professor Sir Michael Brady, at Oxford
University’s Medical Vision Laboratory centre.
Caseaccess is Mirada’s third product to be launched into the
global marketplace in the last 12 months. It allows efficient
dissemination of patient imaging information and reporting via
sophisticated technology that takes image data from the centre where
the patient was scanned and makes this available to the referring
physician regardless of where the referrer is located.
This provides significant technological advantages over currently
available report distribution mechanisms. These often use slow and
unreliable methods, such as posting a CD containing the image data
and report, or relaying patient information via inefficient web
based packages and tools that prevent the referring physician from
being able to fully and clearly understand the patient’s condition.
Chief Technology Officer, Dr Timor Kadir said: “The purpose of
healthcare IT is to increase workflow efficiency while assisting
clinical users to obtain the best possible quality of information
from the raw data. Both imaging centres and referrers will benefit
from Mirada’s new Caseaccess product. Caseaccess reliably and
rapidly disseminates all of the available data and information which
has been acquired, certainly boosting productivity and enabling an
improved level of communication and understanding, particularly for
the referring physician.”
Hugh Bettesworth, CEO of Mirada Medical, added: “We are delighted
to be launching another new product that supports decision makers
and the ongoing management of complex disease such as cancer. Mirada
continues to be clinically and commercially focused and aims to
deliver better healthcare solutions in the critical field of cancer
imaging. We are penetrating new markets internationally and enjoying
a growing presence in our key US market.”